Add ANI As A Trusted Source For Reliable Information
Search For "biogencell"
Updated : 1 year, 5 months ago IST
Netanya-based biotechnology startup BioGenCell announced it has received the US Food and Drug Administration's Fast Track Designation for BGC101, a personalized cell therapy for severe Critical Limb Threatening Ischemia (CLTI).